Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
MDT [NYSE]
Medtronic, Inc.
IndexS&P 500 P/E20.78 EPS (ttm)3.02 Insider Own0.10% Shs Outstand996.19M Perf Week0.56%
Market Cap62.52B Forward P/E14.51 EPS next Y4.32 Insider Trans-1.48% Shs Float995.73M Perf Month-2.47%
Income3.07B PEG3.12 EPS next Q0.92 Inst Own88.50% Short Float4.98% Perf Quarter7.37%
Sales17.01B P/S3.68 EPS this Y-10.40% Inst Trans9.25% Short Ratio6.40 Perf Half Y11.22%
Book/sh19.44 P/B3.23 EPS next Y6.87% ROA8.40% Target Price71.69 Perf Year15.09%
Cash/sh14.30 P/C4.39 EPS next 5Y6.67% ROE16.10% 52W Range50.23 - 65.19 Perf YTD10.38%
Dividend1.22 P/FCF18.14 EPS past 5Y10.40% ROI10.10% 52W High-3.71% Beta1.09
Dividend %1.94% Quick Ratio3.50 Sales past 5Y3.10% Gross Margin74.50% 52W Low24.96% ATR0.98
Employees49247 Current Ratio3.80 Sales Q/Q2.40% Oper. Margin28.30% RSI (14)49.12 Volatility1.26% 1.39%
OptionableYes Debt/Eq0.61 EPS Q/Q-53.70% Profit Margin18.00% Rel Volume1.13 Prev Close62.76
ShortableYes LT Debt/Eq0.53 EarningsAug 19 BMO Payout36.70% Avg Volume7.74M Price62.77
Recom1.90 SMA20-0.82% SMA500.91% SMA2006.91% Volume4,164,489 Change0.02%
18-Jun-14Upgrade Barclays Equal Weight → Overweight $67 → $73
18-Jun-14Reiterated Oppenheimer Outperform $66 → $73
17-Jun-14Upgrade RBC Capital Mkts Sector Perform → Outperform $61 → $73
16-Jun-14Upgrade William Blair Mkt Perform → Outperform
21-May-14Reiterated Deutsche Bank Buy $68 → $70
31-Mar-14Reiterated Oppenheimer Outperform $65 → $67
20-Nov-13Reiterated Barclays Equal Weight $60 → $62
20-Nov-13Downgrade Argus Buy → Hold
30-Oct-13Reiterated Barclays Equal Weight $56 → $60
23-Oct-13Upgrade Deutsche Bank Hold → Buy
17-Jul-13Reiterated Argus Buy $54 → $63
22-May-13Reiterated Wunderlich Hold $46 → $53
22-May-13Reiterated Oppenheimer Outperform $52 → $57
20-May-13Reiterated Mizuho Buy $52 → $55
12-Apr-13Reiterated Deutsche Bank Hold $46 → $51
01-Apr-13Reiterated Oppenheimer Outperform $49 → $52
22-Feb-13Reiterated Argus Buy $48 → $54
20-Feb-13Reiterated Barclays Equal Weight $45 → $48
19-Feb-13Reiterated Mizuho Buy $49 → $52
15-Feb-13Reiterated RBC Capital Mkts Sector Perform $41 → $47
29-Jul-14 10:45AM  "Smart pill" firm Proteus raises $172 million Reuters
12:00AM  Democrats Seek U.S. Contract Ban to Discourage Inversions at Bloomberg
28-Jul-14 02:41PM  How Obama Could End Walgreen's Tax-Inversion Hopes at Investor's Business Daily
12:45PM  Medtronic Receives FDA Approval for PRESTIGE┬« LP Cervical Disc System Thomson Reuters ONE
12:35PM  Bankers push 'tax-dodge' M&A deals Reuters
09:40AM  Hospira Eyeing Bid For Danone Unit in Latest Tax Deal at TheStreet
08:31AM  Medtronic Completes Acquisition of Visualase, Inc. Thomson Reuters ONE
08:15AM  [video] Inversion shame gone: NYT reporter at CNBC
12:01AM  Obama could curb corporate 'inversions' on his own -ex-U.S. official Reuters
26-Jul-14 01:42PM  Walgreens eyes loophole end run around taxes at USA TODAY
25-Jul-14 12:48PM  [$$] Three Ways to Play the 'Inversion' Boom at The Wall Street Journal
12:17PM  Covidien Beats on Q3 Earnings but Revenues Miss Zacks
09:07AM  MARK CUBAN: If You're Company Is Moving For Tax Reasons, I'm Selling Your Stock Business Insider
09:07AM  MARK CUBAN: If Your Company Is Moving For Tax Reasons, I'm Selling Your Stock Business Insider
08:23AM  Obama Goes On The Attack Against Companies Doing Inversions To Move To Countries Where They Pay Less In Taxes Business Insider
06:30AM  Obama calls on Congress to end inversion deals, NY Times reports at theflyonthewall.com
24-Jul-14 07:04PM  Obama steps up criticism of tax inversions at USA TODAY
11:45AM  Some Senate Democrats Wary as Obama Fights Tax Inversions at Bloomberg
10:06AM  Covidien Earnings Preview: Has Merger News Shaken Expectations? Benzinga
07:30AM  How to stop corporations from fleeing the U.S. tax laws at MarketWatch
06:40AM  These deals may suffer in US 'inversion' crackdown at CNBC
06:02AM  These deals may suffer in U.S. 'inversion' crackdown at CNBC
06:00AM  Obama to Make Campaign Pitch on Corporate Tax Avoidance at Bloomberg
23-Jul-14 11:32AM  Narrow Push on Overseas Tax Breaks Advances in Senate at Bloomberg
11:19AM  Trader sees Medtronic holding firm optionMONSTER
09:41AM  [video] Faber Report: Inversion train rolling at CNBC
22-Jul-14 02:04PM  Senate Panel Takes On Tax Inversions at New York Times
11:02AM  Bovie Medical: Little Bovie May Be Running With The Big Dogs at Seeking Alpha
21-Jul-14 02:00PM  Why the Nasdaq is going to 5000 this year Yahoo Finance
02:00PM  M&A frenzy will lead to Nasdaq 5000 this year Yahoo Finance
11:34AM  Tax inversions allow firms to avoid state taxes at USA TODAY
09:33AM  AbbVie Gets Its 'Tax Break' In Shire at Seeking Alpha
18-Jul-14 01:10PM  5 New Medical Technologies For Diabetics Benzinga
12:51PM  Key GOP senator signals readiness for inversion deal, The Hill says theflyonthewall.com
11:42AM  AbbVie, Shire agree on $55B combination AP
07:50AM  AbbVie, Shire agree on $55B combination AP
17-Jul-14 05:23PM  MEDTRONIC INC Files SEC form 8-K, Other Events EDGAR Online
04:31PM  3 Key Takeaways From St. Jude Medical Stock's Earnings at Motley Fool
02:03PM  Hatch Open to Some Near-Term Steps Addressing Inversions at Bloomberg
12:25PM  Democrats Rally Against Tax Deals With Eye on Elections at Bloomberg
16-Jul-14 06:23PM  Congress And Tax Inversions: A Wall Streeter's Take On 2014 at Forbes
06:10PM  Abbott, St. Jude Top Views, But Stocks Under Pressure at Investor's Business Daily
05:03PM  St. Jude Medical, Inc. Still Feeling the Love at Motley Fool
03:55PM  U.S. Treasury urges Congress to act on corporate tax dodge deals Reuters
02:02PM  U.S. Treasury urges Congress to act on corporate tax dodge deals Reuters
01:32PM  Slim chances seen for tax 'inversion' clampdown, analysts say at MarketWatch
12:09PM  Why Medtronic (MDT) Stock Is Down Today at TheStreet
11:58AM  U.S. Treasury urges Congress to act on corporate tax dodge deals Reuters
10:58AM  Slim chances seen for tax 'inversion' clampdown, analysts say at MarketWatch
10:36AM  Treasury calls on Congress to halt inversion deals at theflyonthewall.com
09:30AM  Treasury Urges End to Foreign Tax Flights, Though Congress Is Unlikely to Act Soon at New York Times
09:30AM  Treasury Urges End to Foreign Tax Flights, but Quick Action Is Unlikely at New York Times
09:30AM  Obama Administration Seeks End to Inversion Deals at New York Times
15-Jul-14 10:53PM  Lew Seeks Immediate Retroactive Law to Curb Inversions at Bloomberg
09:03AM  Medtronic Sets Pace for Future Growth at Motley Fool
14-Jul-14 05:20PM  Stryker Continues Growth Spree via Acquisitions Zacks
05:00PM  What happens if the Time Warner CableComcast deal breaks? Market Realist
04:51PM  Medtronic Not Sticking Around To Rearrange Chairs On The Titanic at Seeking Alpha
01:46PM  Shorts Are Piling Into These Stocks. Should You Be Worried? at Motley Fool
12:58PM  Wyden Probing Economic Harm Caused by NSA Surveillance at Bloomberg
10:25AM  Mylan To Acquire Non-U.S. Business From Abbott For $5.3 Billion at Forbes
05:51AM  Should You Avoid The 5 Lowest Yielding Dividend Aristocrats? at Seeking Alpha
13-Jul-14 08:32PM  Johnson & Johnson Prescribes Healthy Returns Without M&A or Breakup at TheStreet
08:06AM  Tax Inversions: Why Are They So Popular? at Motley Fool
09-Jul-14 01:42PM  Irish-based M&A surges on back of U.S. companies' tax inversion deals Reuters
12:03PM  Salix Pharmaceuticals to Buy Irish Company and Reincorporate Overseas at New York Times
08:37AM  Ahead of the Bell: Salix Pharma to buy Cosmo Tech AP
12:19AM  [$$] AbbVie Raises Offer for Shire at The Wall Street Journal
08-Jul-14 10:54PM  [$$] AbbVie Raises Offer for Shire at The Wall Street Journal
10:35PM  Study Explores Expanded Use For Edwards' And Medtronic's New Heart Valves at Forbes
09:39PM  [$$] AbbVie Raises Offer for Shire at The Wall Street Journal
08:51PM  [$$] AbbVie Raises Offer for Shire at The Wall Street Journal
07:03PM  In Deal to Cut Corporate Taxes, Shareholders Pay the Price at New York Times
03:11PM  Punishing Walgreen For Leaving The U.S. Might Be More Complicated Than Robert Reich Thinks at Forbes
02:37PM  Tax Inversions: A Look at Five Cross-Border Deals with Big Price Tags at The Wall Street Journal
12:17PM  Deutsche Bank Reiterates On Medtronic And Covidien Amid Acquisition Proposal Benzinga
11:17AM  AbbVie Pushes Shire Bid Over $51 Billion at Forbes
10:13AM  [$$] AbbVie Raises Offer for Shire at The Wall Street Journal
10:03AM  [$$] AbbVie Raises Offer for Shire at The Wall Street Journal
08:50AM  [$$] AbbVie Raises Offer for Shire at The Wall Street Journal
07-Jul-14 04:58PM  More U.S. companies doing deals to avoid U.S. taxes - Congress study Reuters
12:23PM  Companies Look Overseas for Acquisitions and Lower Taxes at The Wall Street Journal
10:45AM  Moody's: Healthcare Quarterly looks at credit implications of M&A surge in industry at Moody's
09:00AM  Why consider possible IntegrysWisconsin Energy merger scenarios? Market Realist
09:00AM  $40 Billion Hospital Supplier Links Health Innovators With Clinicians at Forbes
03-Jul-14 01:50PM  Medtronic's MiniMed Insulin Pump: A Key to Type 2 Diabetes Cure Zacks
09:00AM  The strategic rationale for the IntegrysWisconsin Energy deal Market Realist
08:05AM  The Zacks Analyst Blog Highlights: Abbott Laboratories, Medtronic, Johnson and Johnson, Becton, Dickinson and Thermo Fisher Scientific Zacks
02-Jul-14 07:07PM  People with Type 2 Diabetes Achieve Superior Outcomes with Insulin Pumps vs. Multiple Daily Injections Thomson Reuters ONE
05:00PM  China M&A rulings create hot competition for antitrust lawyers Reuters
02:38PM  What do the Twin Cities have the rest of us don't? at CNBC
01:54PM  Should you get involved in the IntegrysWisconsin Energy deal? Market Realist
01:01PM  The Fleeting Benefits of Overseas Corporate Marriages at New York Times
10:02AM  US stocks edge higher in early trading AP
09:47AM  4 Top Performing Health Care Stocks With More Upside Potential Benzinga
01-Jul-14 07:52PM  Danger Ahead for Investors in this $8 Billion Blockbuster at Motley Fool
02:56PM  India Coronary Stent Market Would Continue to Grow in Double Digits and Abbott Vascular (NYSE:ABT) to Lead the Market PR Newswire
11:14AM  Study Offers Reassurance About Newer Drug-Eluting Stents at Forbes
30-Jun-14 04:31PM  1 Critical Question Swirling Around Medtronic's Mega-Merger at Motley Fool
28-Jun-14 07:00AM  Stock-Picking Increasingly Critical in Health Care Morningstar
Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. It operates through three segments: Cardiac and Vascular Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group's products include pacemakers; insertable cardiac monitors; implantable defibrillators; leads and delivery systems; ablation products; electrophysiology catheters; products for the treatment of atrial fibrillation; information systems for the management of patients with cardiac rhythm disease management devices; products to reduce surgical site infections; coronary and peripheral stents and related delivery systems; therapies for uncontrolled hypertension; endovascular stent graft systems; heart valve replacement technologies; cardiac tissue ablation systems; and open heart and coronary bypass grafting surgical products. The Restorative Therapies Group offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, and throat; and systems that incorporate advanced energy surgical instruments. It also manufactures and sells image-guided surgery and intra-operative imaging systems. The Diabetes Group's products include insulin pumps; continuous glucose monitoring systems; insulin pump consumables; and Web-based therapy management software solutions. The company serves hospitals, physicians, clinicians, and patients in approximately 140 countries. Medtronic, Inc. was founded in 1949 and is headquartered in Minneapolis, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Szyman Catherine MSrVP & Pres DiabetesApr 17Option Exercise49.2929,4201,450,08651,022Apr 21 04:14 PM
Szyman Catherine MSrVP & Pres DiabetesApr 17Sale58.7929,4201,729,51921,602Apr 21 04:14 PM
Kuntz RichardSrVP & Chief Scien, Clin, RegApr 09Sale60.982,512153,182104,736Apr 11 08:42 AM
Ellis Gary LeeSrVP & Chief Financial OfficerApr 01Option Exercise50.464,246214,253179,201Apr 03 02:44 PM
Ellis Gary LeeSrVP & Chief Financial OfficerApr 01Sale61.484,246261,034174,955Apr 03 02:44 PM
OConnell Christopher JEVP & GroupPres Restora TherapMar 28Option Exercise50.461,982100,012122,634Mar 31 03:00 PM
OConnell Christopher JEVP & GroupPres Restora TherapMar 28Sale60.391,982119,696120,652Mar 31 03:00 PM
Szyman Catherine MSrVP & Pres DiabetesMar 20Option Exercise35.0514,979524,99836,521Mar 21 03:14 PM
Szyman Catherine MSrVP & Pres DiabetesMar 20Sale59.5714,979892,33821,542Mar 21 03:14 PM
ISHRAK OMARChairman & CEOMar 14Sale59.1210,000591,227607,192Mar 17 02:00 PM
AYOTTE NEIL PVP Interim Gen Counsel CorpSecMar 10Sale59.641,845110,04110,782Mar 11 04:07 PM
AYOTTE NEIL PVP Interim Gen Counsel CorpSecFeb 28Option Exercise50.003,500175,00014,398Mar 03 05:28 PM
AYOTTE NEIL PVP Interim Gen Counsel CorpSecFeb 28Sale59.541166,90710,782Mar 03 05:28 PM
AYOTTE NEIL PVP Interim Gen Counsel CorpSecDec 04Sale57.141,72998,79710,850Dec 04 06:56 PM
ISHRAK OMARChairman & CEOSep 13Sale53.5810,000535,803611,713Sep 16 05:35 PM
Szyman Catherine MSrVP & Pres DiabetesAug 26Option Exercise43.1053,4182,302,44678,215Aug 28 06:42 PM
Szyman Catherine MSrVP & Pres DiabetesAug 26Sale52.6056,9982,998,33421,217Aug 28 06:42 PM
OLEARY DENISE MDirectorAug 23Option Exercise49.586,052300,05831,441Aug 27 01:49 PM
ANDERSON RICHARD HDirectorAug 22Option Exercise49.584,842240,06636,323Aug 23 01:21 PM
Dallas H JamesSrVP Quality, Operations, ITAug 22Sale53.1932,3321,719,76859,141Aug 23 01:21 PM
JACKSON SHIRLEY ADirectorAug 21Option Exercise43.578,723380,08132,976Aug 22 05:00 PM
Dallas H JamesSrVP Quality, Operations, ITAug 21Option Exercise36.7438,9991,432,987127,729Aug 22 05:07 PM
Dallas H JamesSrVP Quality, Operations, ITAug 21Sale52.8236,2561,915,09391,473Aug 22 05:07 PM
JACKSON SHIRLEY ADirectorAug 21Sale52.848,033424,44424,943Aug 22 05:00 PM